| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2022 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 12 | Q3 2016 | 14.4% |
| LILLY ELI & CO | 12 | Q3 2016 | 20.0% |
| ALEXION PHARMACEUTICALS INC | 11 | Q3 2016 | 15.1% |
| MALLINCKRODT PUB LTD CO | 8 | Q3 2015 | 7.0% |
| UNITED THERAPEUTICS CORP DEL | 7 | Q3 2015 | 11.7% |
| REGENERON PHARMACEUTICALS | 7 | Q3 2016 | 14.6% |
| UNIVERSAL HLTH SVCS INC | 7 | Q2 2015 | 12.1% |
| ZOETIS INC | 7 | Q3 2016 | 5.2% |
| INCYTE CORP | 6 | Q4 2015 | 14.7% |
| EDWARDS LIFESCIENCES CORP | 5 | Q3 2016 | 28.5% |
View March Altus Capital Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2016-11-07 |
| 13F-HR | 2016-07-27 |
| 13F-HR | 2016-05-12 |
| 13F-HR | 2016-02-16 |
| 13F-HR | 2015-11-16 |
| 13F-HR | 2015-08-14 |
| 13F-HR | 2015-05-15 |
| 13F-HR | 2015-02-17 |
| 13F-HR | 2014-11-14 |
| 13F-HR | 2014-08-14 |
View March Altus Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.